These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 38550582)

  • 1. Mitochondrial extracellular vesicles, autoimmunity and myocarditis.
    Di Florio DN; Beetler DJ; McCabe EJ; Sin J; Ikezu T; Fairweather D
    Front Immunol; 2024; 15():1374796. PubMed ID: 38550582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.
    Massilamany C; Gangaplara A; Reddy J
    Int J Cardiol; 2014 Dec; 177(2):330-339. PubMed ID: 25449464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis.
    Meyer IS; Goetzke CC; Kespohl M; Sauter M; Heuser A; Eckstein V; Vornlocher HP; Anderson DG; Haas J; Meder B; Katus HA; Klingel K; Beling A; Leuschner F
    Front Immunol; 2018; 9():2303. PubMed ID: 30349538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
    Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity in coxsackievirus infection.
    Rose NR
    Curr Top Microbiol Immunol; 2008; 323():293-314. PubMed ID: 18357776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
    Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
    Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on coxsackievirus B3 myocarditis.
    Fairweather D; Stafford KA; Sung YK
    Curr Opin Rheumatol; 2012 Jul; 24(4):401-7. PubMed ID: 22488075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis.
    Neumann DA; Rose NR; Ansari AA; Herskowitz A
    J Immunol; 1994 Jan; 152(1):343-50. PubMed ID: 8254202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of myocarditis and dilated cardiomyopathy.
    Cihakova D; Rose NR
    Adv Immunol; 2008; 99():95-114. PubMed ID: 19117533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in inflammation, redox biology, mitochondria and autoimmunity.
    Di Florio DN; Sin J; Coronado MJ; Atwal PS; Fairweather D
    Redox Biol; 2020 Apr; 31():101482. PubMed ID: 32197947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis.
    Liu X; Li M; Chen Z; Yu Y; Shi H; Yu Y; Wang Y; Chen R; Ge J
    Basic Res Cardiol; 2022 Aug; 117(1):40. PubMed ID: 35997820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis.
    Horwitz MS; Ilic A; Fine C; Sarvetnick N
    J Autoimmun; 2005 Sep; 25(2):102-11. PubMed ID: 16011890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose inorganic mercury increases severity and frequency of chronic coxsackievirus-induced autoimmune myocarditis in mice.
    Nyland JF; Fairweather D; Shirley DL; Davis SE; Rose NR; Silbergeld EK
    Toxicol Sci; 2012 Jan; 125(1):134-43. PubMed ID: 21984480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
    Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent coxsackievirus infection: enterovirus persistence in chronic myocarditis and dilated cardiomyopathy.
    Chapman NM; Kim KS
    Curr Top Microbiol Immunol; 2008; 323():275-92. PubMed ID: 18357775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis.
    Ho HT; Peischard S; Strutz-Seebohm N; Seebohm G
    Cell Physiol Biochem; 2021 Nov; 55(6):679-703. PubMed ID: 34791861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and experimental aspects of viral myocarditis.
    Leslie K; Blay R; Haisch C; Lodge A; Weller A; Huber S
    Clin Microbiol Rev; 1989 Apr; 2(2):191-203. PubMed ID: 2650861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune myocarditis, valvulitis, and cardiomyopathy.
    Myers JM; Fairweather D; Huber SA; Cunningham MW
    Curr Protoc Immunol; 2013; Chapter 15():Unit 15.14.1-51. PubMed ID: 23564686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.